Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ACT-385781A (Actelion Epoprostenol)
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
2Current marketed FLOLAN (epoprostenol sodium)
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
3EPOPROSTENOL
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
4Epoprostenol for injection
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
5EPOPROSTENOL SODICO
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
6EPOPROSTENOL SODIUM
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
7Epoprostenol-Actelion
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
8New thermo stable formulation of epoprostenol sodium
(Synonym: D00106)		[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86